Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management

por Al-Janabi, A, Yiu, Z Z N
Publicado 2022

Giant condylomata acuminata of Buschke and Lowenstein: A peristomal variant

por Yiu, Z.Z.N., Ali, F.R., Wilson, M.S., Mowatt, D., Lyon, C.C.
Publicado 2014

Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta‐analysis of randomized controlled trials

por Rungapiromnan, W., Yiu, Z.Z.N., Warren, R.B., Griffiths, C.E.M., Ashcroft, D.M.
Publicado 2017

Risk of COVID‐19 infection in adult patients with atopic eczema and psoriasis: a single‐centre cross‐sectional study

por Yiu, Z.Z.N., Harding‐Oredugba, G., Griffiths, C.E.M., Warren, R.B., McMullen, E., Hunter, H.J.A.
Publicado 2021

Antibody responses to single‐dose SARS‐CoV‐2 vaccination in patients receiving immunomodulators for immune‐mediated inflammatory disease

por Al‐Janabi, A., Littlewood, Z., Griffiths, C.E.M., Hunter, H.J.A., Chinoy, H., Moriarty, C., Yiu, Z.Z.N., Warren, R.B.
Publicado 2021

Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy

por Yiu, Z.Z.N., Sorbe, C., Lunt, M., Rustenbach, S.J., Kühl, L., Augustin, M., Mason, K.J., Ashcroft, D.M., Griffiths, C.E.M., Warren, R.B.
Publicado 2019

A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis

por Yiu, Z.Z.N., Mason, K.J., Barker, J.N.W.N., Hampton, P.J., McElhone, K., Smith, C.H., Warren, R.B., Griffiths, C.E.M., Lunt, M., Burden, A.D.
Publicado 2019

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermato...

por Yiu, Z.Z.N., Ashcroft, D.M., Evans, I., McElhone, K., Lunt, M., Smith, C.H., Walton, S., Murphy, R., Reynolds, N.J., Ormerod, A.D., Griffiths, C.E.M., Warren, R.B.
Publicado 2018

Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review

por Mason, K.J., Williams, S., Yiu, Z.Z.N., McElhone, K., Ashcroft, D.M., Kleyn, C.E., Jabbar‐Lopez, Z.K., Owen, C.M., Reynolds, N.J., Smith, C.H., Wilson, N., Warren, R.B., Griffiths, C.E.M.
Publicado 2019

Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey(*)

por Mahil, S.K., Yates, M., Langan, S.M., Yiu, Z.Z.N., Tsakok, T., Dand, N., Mason, K.J., McAteer, H., Meynell, F., Coker, B., Vincent, A., Urmston, D., Vesty, A., Kelly, J., Lancelot, C., Moorhead, L., Bachelez, H., Bruce, I.N., Capon, F., Contreras, C.R., Cope, A.P., De La Cruz, C., Di Meglio, P., Gisondi, P., Hyrich, K., Jullien, D., Lambert, J., Marzo‐Ortega, H., McInnes, I., Naldi, L., Norton, S., Puig, L., Sengupta, R., Spuls, P., Torres, T., Warren, R.B., Waweru, H., Weinman, J., Griffiths, C.E.M., Barker, J.N., Brown, M.A., Galloway, J.B., Smith, C.H.
Publicado 2021